Loading...

Canopy Growth Corporation

CGCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.05
$0.02(1.94%)

Canopy Growth Corporation (CGC) Stock Competitors & Peer Comparison

See (CGC) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CGC$1.05+1.94%239M-0.26-$4.08N/A
ZTS$147.38+1.09%65.6B26.46$5.57+1.31%
HLN$9.66+2.49%44.9B21.99$0.44+1.74%
TAK$14.16+3.21%44.7B48.83$0.29+4.15%
TEVA$15.38-0.45%17.7B-102.63-$0.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$128.91+0.53%12.8B38.03$3.39N/A
RDY$13.94-1.97%11.6B17.87$0.78+0.51%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$8.81+0.80%10.3B-2.77-$3.18+5.44%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CGC vs ZTS Comparison August 2025

CGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGC stands at 239M. In comparison, ZTS has a market cap of 65.6B. Regarding current trading prices, CGC is priced at $1.05, while ZTS trades at $147.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGC currently has a P/E ratio of -0.26, whereas ZTS's P/E ratio is 26.46. In terms of profitability, CGC's ROE is -1.13%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, CGC is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for CGC.Check ZTS's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;